Compliance with osteoporosis drug therapy and risk of fracture (original) (raw)
Compliance with drug therapies for the treatment and prevention of osteoporosis
C. McLaughlin-miley
Maturitas, 2004
View PDFchevron_right
Methods to examine the impact of compliance to osteoporosis pharmacotherapy on fracture risk: systematic review and recommendations
Milica Nikitovic
Therapeutic Advances in Chronic Disease, 2010
View PDFchevron_right
Determinants of Oral Medication Compliance in Osteoporosis: The Role of Medication Beliefs
John Schousboe MD PhD
View PDFchevron_right
Medication selection and patient compliance in the clinical management of osteoporosis
Charles Inderjeeth
PubMed, 2016
View PDFchevron_right
Relationship between compliance and persistence with osteoporosis medications and fracture risk in primary health care in France: A retrospective case—control analysis
François-emery Cotte, Florence Mercier
Clinical Therapeutics, 2008
View PDFchevron_right
Patient Adherence to Osteoporosis Medications
Jonathan Adachi
Drugs & Aging, 2007
View PDFchevron_right
Relationship between compliance and persistence with osteoporosis medications and fracture risk in primary health care in France: A retrospective case--control …
Florence Mercier
Clinical therapeutics, 2008
View PDFchevron_right
A systematic review of factors affecting medication adherence among patients with osteoporosis
Jun Jie Benjamin Seng
Osteoporosis International, 2018
View PDFchevron_right
Compliance with drug therapy for postmenopausal osteoporosis
Gerry Oster
Osteoporosis International, 2006
View PDFchevron_right
Compliance and persistence with osteoporosis medications: A critical review of the literature
Stuart Silverman
Reviews in Endocrine and Metabolic Disorders, 2010
View PDFchevron_right
Non-Adherence to Anti-Osteoporosis Medication: Factors Influencing and Strategies to Overcome It. A Narrative Review
Marianna Avola
Journal of Clinical Medicine
View PDFchevron_right
Compliance of osteoporotic patients with different treatment regimens
S. Ish-shalom
The Israel Medical Association journal : IMAJ, 2003
View PDFchevron_right
Patterns of Anti-Osteoporosis Medication Use among Women at High Risk of Fracture: Findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW)
Jonathan Adachi, Frederick Hooven
PLoS ONE, 2013
View PDFchevron_right
Adherence to osteoporosis pharmacotherapy one year after osteoporotic fracture - a Swiss trauma center secondary prevention project
Felix Amsler
Swiss Medical Weekly
View PDFchevron_right
Compliance and treatment satisfaction of post menopausal women treated for osteoporosis. Compliance with osteoporosis treatment
Chantal Rousseaux
BMC Women's Health, 2010
View PDFchevron_right
Primary and secondary non-adherence to osteoporotic medications after hip fracture in Spain. The PREV2FO population-based retrospective cohort study
Gabriel Sanfélix-Gimeno
Scientific Reports
View PDFchevron_right
If you don't take it – it can't work: the consequences of not being treated or nonadherence to osteoporosis therapy
Jonathan Adachi
Therapeutics and Clinical Risk Management, 2011
View PDFchevron_right
Medication persistence in older women with osteoporosis: A pilot study
Dawn M Goel
View PDFchevron_right
Adherence with osteoporosis practice guidelines: A multilevel analysis of patient, physician, and practice setting characteristics
Shimon Shaykevich
The American Journal of Medicine, 2004
View PDFchevron_right
Systematic Review and Meta-analysis of Real-World Adherence to Drug Therapy for Osteoporosis
Ron Halbert
Mayo Clinic Proceedings, 2007
View PDFchevron_right
A New Look at Osteoporosis Outcomes: The Influence of Treatment, Compliance, Persistence, and Adherence
Enkhe Badamgarav
Mayo Clinic Proceedings, 2006
View PDFchevron_right
Factors associated with treatment of women with osteoporosis or osteopenia from a national survey
Nananda Col, Eric Meadows
BMC Women's Health, 2012
View PDFchevron_right
Efficacy, side-effects and route of administration are more important than frequency of dosing of anti-osteoporosis treatments in determining patient preference and compliance: A critical review of published articles from 1970-2009
Charles Inderjeeth
Bone, 2010
View PDFchevron_right
Efficacy, side effects and route of administration are more important than frequency of dosing of anti-osteoporosis treatments in determining patient adherence: a critical review of published articles from 1970 to 2009
Charles Inderjeeth
Osteoporosis International, 2011
View PDFchevron_right
Patient Decision to Initiate Therapy for Osteoporosis: The Influence of Knowledge and Beliefs
Kristijan Kahler
Journal of General Internal Medicine, 2008
View PDFchevron_right
Prevalence of osteoporosis and fractures among women prescribed osteoporosis medication in five European countries: the POSSIBLE EU ® study
LUC MARTINEZ
Osteoporosis International, 2011
View PDFchevron_right
Therapeutic adherence to osteoporosis treatment
S. Tomková
International journal of clinical pharmacology and therapeutics, 2014
View PDFchevron_right
Long-term impact of adherence to oral bisphosphonates on osteoporotic fracture incidence
john sampalis
Journal of Bone and Mineral Research, 2011
View PDFchevron_right
Knowledge and compliance from patients with postmenopausal osteoporosis treatment
Francisco Quereda, José Luis Neyro
Menopause International, 2009
View PDFchevron_right